The modern abdominoperineal excision: The next challenge after total mesorectal excision

Annals of Surgery

Volumn 242, Issue 1, 2005, Pages 74-82

  Marr, Roger ^a   Birbeck, Kevin ^a   Garvican, James ^a   Macklin, Christopher P ^a   Tiffin, Nicholas J ^a   Parsons, Wendy J ^a   Dixon, Michael F ^a,b   Mapstone, Nicholas P ^a,b   Sebag Montefiore, David ^a   Scott, Nigel ^a   Johnston, David ^a   Sagar, Peter ^a   Finan, Paul ^a   Quirke, Philip ^a,b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; ANASTOMOSIS, SURGICAL; BIOPSY, NEEDLE; COHORT STUDIES; COLORECTAL SURGERY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TISSUE CULTURE TECHNIQUES;

EID: 21444435032     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000167926.60908.15     Document Type: Article

References (23)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg. 1982;69:613-616.
2. Heald RJ. Rectal cancer: the surgical options. Ear J Cancer. 1995;31A: 1189-1192.
3. Heald RJ, Smedh RK, Kald A, et al. Abdominoperineal excision of the rectum: an endangered operation [Norman Nigro Lectureship]. Dis Colon Rectum. 1997;40:747-751.
4. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm: Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93-96.
5. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer: implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857-866.
6. Kapiteijn E, Kranenbarg EK, Steup WH, et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer: prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg. 1999;165:410-420.
7. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
8. Marijnen CA, Kapiteijn E, van De Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20:817-825.
9. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-457.
10. Heald RJ, Moran BJ. Embryology and anatomy of the rectum. Semin Surg Oncol. 1998;15:66-71.
11. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344:707-711.
12. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327-334.
13. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26:350-357.
14. Nagtegaal ID, van de Velde CJ, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734.
15. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis. 1988;3:127-131.
16. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2: 996-999.
17. Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today. 1995;25:795-801.
18. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19:1976-1984.
19. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology. 1999;211: 215-222.
20. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497-504.
21. National Institutes of Health. Consensus conference: adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-1450.
22. Miles WE. A method of performing abdomino perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908;2:1812-1813.
23. Miles WE. The radical abdomino-perineal operation for cancer of the pelvic colon. BMJ. 1910;941-943.